- Home
- BME vs CCAP Comparison
BME vs CCAP Comparison
Compare BME & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BME
- CCAP
- Stock Information
- Founded
- BME 2005
- CCAP 2015
- Country
- BME United States
- CCAP United States
- Employees
- BME N/A
- CCAP N/A
- Industry
- BME Trusts Except Educational Religious and Charitable
- CCAP Finance: Consumer Services
- Sector
- BME Finance
- CCAP Finance
- Exchange
- BME Nasdaq
- CCAP Nasdaq
- Market Cap
- BME 462.3M
- CCAP 534.1M
- IPO Year
- BME N/A
- CCAP N/A
- Fundamental
- Price
- BME $36.35
- CCAP $14.10
- Analyst Decision
- BME
- CCAP Buy
- Analyst Count
- BME 0
- CCAP 5
- Target Price
- BME N/A
- CCAP $17.60
- AVG Volume (30 Days)
- BME 34.0K
- CCAP 304.2K
- Earning Date
- BME 01-01-0001
- CCAP 08-11-2025
- Dividend Yield
- BME 6.26%
- CCAP 14.11%
- EPS Growth
- BME N/A
- CCAP N/A
- EPS
- BME 1.44
- CCAP 1.34
- Revenue
- BME N/A
- CCAP $189,131,000.00
- Revenue This Year
- BME N/A
- CCAP N/A
- Revenue Next Year
- BME N/A
- CCAP N/A
- P/E Ratio
- BME $28.37
- CCAP $10.55
- Revenue Growth
- BME N/A
- CCAP N/A
- 52 Week Low
- BME $35.53
- CCAP $13.54
- 52 Week High
- BME $43.20
- CCAP $20.19
- Technical
- Relative Strength Index (RSI)
- BME 55.94
- CCAP 34.84
- Support Level
- BME $35.30
- CCAP $14.19
- Resistance Level
- BME $36.49
- CCAP $14.64
- Average True Range (ATR)
- BME 0.37
- CCAP 0.32
- MACD
- BME 0.05
- CCAP 0.01
- Stochastic Oscillator
- BME 82.27
- CCAP 9.48
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
About CCAP Crescent Capital BDC Inc. Common stock
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.